FLASCO 2026 Clinical Oncology Series - Malignant Hematology

Join us for a comprehensive exploration of the rapidly evolving field of malignant hematology, where leading experts will examine the latest advances shaping the diagnosis and treatment of hematologic malignancies. This focused program will highlight emerging data, precision medicine strategies, and innovative therapeutic approaches that are transforming care for patients with complex blood cancers. Through expert-led discussions and evidence-based insights, participants will explore key developments in targeted therapies, cellular treatments, and biomarker-driven decision making across a range of hematologic malignancies. Attendees will gain practical perspectives on integrating new clinical evidence into everyday practice while navigating the challenges of delivering personalized care in a rapidly advancing field.

Please note: Industry participation is limited to exhibit sponsors only.